$VRME

VerifyMe, Inc. (VRME): Entry into a Material Definitive Agreement

VerifyMe, Inc. (VRME) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0001104038 0001104038 2026-08-10 2026-08-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Repor

Original reporting
Published Aug 12, 2026, 6:50 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 6:54 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$VRME
Neutral
medium confidence
Mentioned
$VRME
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$VRMENeutralMed
01

Why it matters

This 8-K reports the third amendment effective Aug. 10, 2026, extending the merger outside date from Aug. 31, 2026 to Oct. 31, 2026.

02

Market read

For deal traders, the key new datapoint is the updated outside date, which can shift deal-spread expectations and near-term risk premium.

03

What to watch

Traders should watch for subsequent amendments, any financing or shareholder-approval conditions in the merger agreement, and whether the target’s own disclosures change the probability of closing by the new date.

Relevance 6/10Novelty 6/10Timing: today’s SEC 8-K, effective Aug. 10, 2026

Background

VerifyMe previously disclosed an Agreement and Plan of Merger with Open World, with amendments dated April 13, 2026 and June 4, 2026.

Company-level read

Ticker impact

$VRMENeutralMedium confidence
Context

VerifyMe filed an 8-K disclosing the third amendment to its Open World merger, extending the outside date to Oct. 31, 2026.

Expected impact

Likely modest, deal-spread driven move rather than a fundamental repricing, with sensitivity to any further amendments or closing milestones.

Evidence & confidence

The filing is a primary-source SEC update on deal mechanics (outside date extension) without new financial terms or definitive closing confirmation.

Market effects

Limited sector read-through; this is company-specific M&A timing rather than industry-wide regulation or demand shift.

No clear regional spillover beyond US microcap deal activity.

Minimal global relevance; involves a Cayman Islands target but no cross-border regulatory decision disclosed.

Counterpoint

The outside-date extension may reflect execution or regulatory friction, so the market could price a lower closing probability despite the reduced technical deadline risk.

Key entities

  • VerifyMe, Inc.

    Nasdaq-listed acquirer whose 8-K reports the merger outside-date extension.

  • Open World, Ltd.

    Cayman Islands exempted company to become a wholly-owned subsidiary upon merger closing.

  • VRME Subsidiary Corp.

    Wholly owned merger subsidiary that will merge into Open World.

Related articles

$VRMEMed

VerifyMe, Inc. (VRME): Results of Operations and Financial Condition

VerifyMe, Inc. (VRME) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99_1.htm EXHIBIT 99.1 Exhibit 99.1 VerifyMe Reports Second Quarter 2026 Financial Results · Quarterly revenue of $1.9 million, compared to $4.5 million in Q2 2025 · Quarterly gross profit of $1.0 million or 54%, compared to $1.6 million or 35% in Q2 2025 · Net loss of

$BABAHighAI 9/10

Alibaba falls 8% after US$10 billion Hong Kong share sale to fund AI spending

Alibaba's shares dropped 8% after a HK$80 billion (US$10.21 billion) share sale to fund AI investments. The company sold 710 million new shares at an 8.4% discount. Proceeds will be used for AI development, including chips and infrastructure. The offering was oversubscribed, with a 90-day lockup period. CEO Eddie Wu emphasized the need for capital expenditure to capture future growth. Investor Michael Burry criticized the share issuance, stating it would lower Alibaba's return on invested capita

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) Binding Agreement Concluded with Mangrove Lithium

Elevra Lithium (ASX:ELV) has signed a binding 7-year spodumene supply agreement with Mangrove Lithium, extendable for another 7 years. The deal secures long-term local supply for Elevra's Quebec operations at market-linked prices with downside protection. Mangrove's facility, pending financing, will avoid Elevra's ocean freight costs. Both companies are backed by Canada Growth Fund.